Elder Pharma employs about 3,300 people in India, with about 2,700 professionals in marketing and sales. This recruitment will help Elder Pharma to have one of the largest drug sales force in India, like market leaders such as Cipla, Ranbaxy, Piramal Healthcare and Lupin.
Elder Pharmaceuticals, one of the fast growing pharmaceutical formulation company, is getting ready to make its maiden overseas acquisition.
Elder Pharmaceuticals Ltd has entered into an alliance with US-based Blistex Inc to manufacture and introduce the latter's entire range of lip care products in India.\n\n\n\n
Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.
Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.
During the said period, the Consumer Complaints Council of ASCI found 15 advertisers, including Reliance Communications and Idea Cellular, fast moving consumer goods player Dabur and Elder Pharma and coaching centre Career Launcher, violating the council's code.
Swiss-based pharma multinational Roche Scientific has finalised a marketing agreement with Elder Pharmaceuticals to sell its new post-menopausal osteoporosis drug, Bonviva, in the country.
Surya Narayan Patra of SSKI & Sharekhan discusses his picks from the pharma space
Global private equity (PE) major Carlyle is in talks with renowned cardiac surgeon Dr Naresh Trehan to acquire a minority stake in his Gurgaon-based multi-super speciality hospital, Medanta -The Medicity.
Analysts are divided on the deal valuations. Some say Torrent could have bargained harder, as Sanofi, among others, passed it over.
It is almost puzzling to see more old men and women hang around long enough for people to begin wondering 'why not retire?'
Keep regular track of financials, including cash flow and management changes
Torrent to buy Ranbaxy's anti-bacterial generic
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances